Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer

John B. Welsh, Lisa M. Sapinoso, Suzanne G. Kern, Garret M. Hampton, Andrew I. Su, Jessica Wang-Rodriguez, Christopher A. Moskaluk, Henry F. Frierson

Research output: Contribution to journalArticlepeer-review

741 Scopus citations

Abstract

Detection, treatment, and prediction of outcome for men with prostate cancer increasingly depend on a molecular understanding of tumor development and behavior. We characterized primary prostate cancer by monitoring expression levels of more than 8900 genes in normal and malignant tissues. Patterns of gene expression across tissues revealed a precise distinction between normal and tumor samples, and revealed a striking group of about 400 genes that were overexpressed in tumor tissues. We ranked these genes according to their differential expression in normal and cancer tissues by selecting for highly and specifically overexpressed genes in the majority of cancers with correspondingly low or absent expression in normal tissues. Several such genes were identified that act within a variety of biochemical pathways and encode secreted molecules with diagnostic potential, such as the secreted macrophage inhibitory cytokine, MIC-1. Other genes, such as fatty acid synthase, encode enzymes known as drug targets in other contexts, which suggests new therapeutic approaches.

Original languageEnglish
Pages (from-to)5974-5978
Number of pages5
JournalCancer Research
Volume61
Issue number16
StatePublished - 15 Aug 2001
Externally publishedYes

Fingerprint

Dive into the research topics of 'Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer'. Together they form a unique fingerprint.

Cite this